The phrase "assessed published" is not correct and does not convey a clear meaning in written English.
It may be intended to describe something that has been evaluated and made public, but the combination of the two words is awkward and unclear.
Example: "The results of the study were assessed and published in a reputable journal."
Alternatives: "evaluated and released" or "reviewed and made public."
But Dr. Martha Daviglus of Northwestern University, who led a panel last year that assessed published papers on preventing and treating Alzheimer's, urged caution.
Ringler et al. (2010) observed variations of sensor conditions in a broad range of frequencies using power levels of background noises at GSN stations, and Davis and Berger (2007) assessed published GSN response information by comparing Earth's tide observations with synthetic tides at 1-day and half-day periods.
We assessed published studies and also the controlled clinical trials database ClinicalTrials.gov.gov
A systematic review by WHO in 2011 that assessed published data for 1995 2009 identified only 2 high-quality studies.
Other potential limitations of the study include that fact that we only assessed published studies written in English and that we used a conservative measure of remission rate.
Objective: This is a systematic review to assess published scientific evidence on preterm birth predictors.
A potential difficulty in assessing published studies is that patient groups can be selected for treatment differently according to how risk categories are defined.
PURPOSE: To review and assess published findings from relevant cancer research studies in Native Hawaiians and other Pacific Islanders and to develop strategies for designing and implementing successful cancer research studies in the future.
To comprehensively assess published randomized peer-reviewed studies related to volatile agents used for sedation in intensive care unit (ICU) settings, with the hypothesis that volatile agents could reduce time to extubation in adult patients.
The objective of this review is to assess published economic evaluation of BEV in the treatment of non-small cell lung cancer (NSCLC).
The aim of this study was to assess published models for prediction of mortality following vvECMO and optimize an alternative model.
